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Background. A “dysexecutive” group of patients with Alzheimer disease (AD) has been previously identiﬁed, and these patients
have been found to present higher frequency of psychiatric symptoms and more pronounced functional impact. This study
aimed at evaluating the frequency of neuropsychiatric symptoms in patients with early AD who present with impaired executive
functioning. Methods. Thirty patients with early AD diagnosis were divided into a spared (SEF) and an impaired (IEF) executive
functioning group according to their performance scores on neuropsychological tests. Their closest relatives or caregivers
completed the Cambridge behavioral inventory (CBI), which assesses behavioral symptoms grouped into 13 categories. Results.A
signiﬁcant diﬀerence was exclusively found between SEF and IEF in terms of the frequency of stereotypies and repetitive motor
behavior (U = 60.5, P = .024). Conclusions. The presence of stereotypies could be associated with a dysexecutive proﬁle in AD
patients.TheseresultsshedlightontheroleoffrontalcircuitryintheexpressionofmotorsymptomsinADandpromptforfurther
research that will contribute to the diﬀerential diagnosis both of diﬀerent subtypes of AD and other types of dementia.
1.Introduction
The identiﬁcation of a subgroup of Alzheimer disease (AD)
patients who present with prominent frontal lobe dysfunc-
tion has gained increasing evidence in the last decade. While
it is recognized that the involvement of the frontal lobes
in AD patients is more subtle than in other degenerative
diseases, such as frontotemporal dementia (FTD), several
studies have shown that executive dysfunction occurs even
in the early stages of the disease [1–4]. This “frontal” group
of AD patients appears to have distinct neuropathological
[5]a n db i o c h e m i c a l[ 6] changes within the frontal cortex,
as well as characteristic neuropsychological proﬁles [7, 8]
relative to patients with “typical” AD who develop the
characteristic features of the disease as expected throughout
time, including early prominent memory impairment. In
fact, it has been recently suggested that disease progression
in this subgroup may be more rapid than in AD patients of
the amnesic (i.e., “typical”) type [7].
From a clinical and functional standpoint, AD patients
with marked dysexecutive functioning tend to present high-
er frequency and severity of neuropsychiatric symptoms
[2, 9–11] and decreased performance on activities of daily
living [2]. Most frequently, studies that have screened for
neuropsychiatric disturbances in AD have employed the
neuropsychiatric inventory (NPI) [12]o ri t sb r i e fc o u n -
terpart NPI questionnaire (NPI-Q) [13], both of which are
carer-based interviews useful in everyday clinical practice
because of its succinct nature. Another useful tool in the
assessment of neuropsychiatric and behavioral impairment
is the Cambridge behavioral inventory (CBI) [14], an in-
formant-based 81-item questionnaire grouped into thirteen2 Current Gerontology and Geriatrics Research
functional/behavioral domains, including memory, orien-
tation and attention, everyday skills, self-care, mood, be-
liefs, challenging behavior, disinhibition, eating habits, sleep,
stereotypic and motor behavior, motivation, and insight/
awareness. Each item is rated on a scale from 0 (never) to 4
(constant occurrence) depending on the frequency with
which the patient exhibits each particular behavior.
WhiletheNPIwasdevelopedinordertocapturetheneu-
ropsychiatric symptoms of patients with dementia of the
Alzheimer type [12], the CBI was originally designed to
detectthebehavioraldisturbancesthatoccurinpatientswith
frontal variant FTD [14]. In this sense, it can be both use-
ful and informative to assess “frontal” AD patients with a
comprehensive questionnaire that taps on multiple behav-
ioral domains typically aﬀected in patients characterized by
involvement of the frontal lobes (i.e., FTD patients).
Inthepresentstudy,theCBIwasusedtocomparethebe-
havioral proﬁle of AD patients who presented spared execu-
tive functions relative to those patients with AD who exhib-
itedmarkeddysexecution.Wehypothesizedthat“frontal”AD
patients would display higher frequency of neuropsychiatric
symptoms than “typical” AD patients, in particular, for
behavioral domains associated with frontal lobe functioning
(e.g., disinhibition).
2. Methods
2.1. Participants. Patients with diagnosis of AD were recruit-
edforthis studyaccordingtothefollowinginclusion criteria:
(a) they fulﬁlled diagnostic criteria according to NINCDS-
ADRDA consensus [15], (b) were in the mild stages of the
disease, as determined by a clinical dementia rating scale
(CDR)scoreof1[16],(c)presentedmedialtemporalatrophy
on MRI, and (d) signed an informed consent together with
their caregiver prior to inclusion in the study. All patients
completed the Beck depression inventory II (BDI-II) [17]
in order to determine the severity of mood symptoms. A
total of 30 AD patients matched these criteria and were
included in the present study together with their closest
caregiver. Caregivers were sons/daughters (73.3% of the
cases), nieces (6.66%), or professional caregivers (20%). It
was determined that the CBI domains had a high interrater
reliability coeﬃcient (mean Cohen’s kappa = .90; range: .87
to .95), as calculated from the cases (30%) for which more
than two independent caregiver reports were available (e.g.,
that of the patient’s son and professional caregiver).
2.2. Procedure. The study was initially approved by the ethics
committee at the Institute of Cognitive Neurology (INECO,
Buenos Aires, Argentina) in accordance with the guidelines
established under the Declaration of Helsinki for research
with human subjects. Following initial neurological inter-
view, during which the aforementioned inclusion criteria
wereconﬁrmedbya specialist cognitive neurologist (FM)for
all participants, patients were assessed by a neuropsycholo-
gistwiththeAddenbrooke’scognitiveexamination—Revised
(ACE-R)[18],ascreeningtooltoassessgeneralcognitivesta-
tusandfourclassicaltestsofexecutivefunctioning,including
working memory with the backward digit span (BckDS) test
[19], phonological ﬂuency (PhFlu) with the number of items
producedwithletter“P”inoneminute[20],set-shiftingwith
the trail making test part B (TMT-B) [21], and ﬂexibility
and abstraction capacity with the modiﬁed version of the
Wisconsincardsortingtest(WCST)[22].Patients’caregivers
were asked to complete the CBI, which was not used for
diagnostic purposes so as to avoid circularity of our ﬁndings.
Patients who were receiving antipsychotic medication were
excluded from this study.
2.3. Statistical analysis. Individual raw scores on the four
classical executive tasks (BckDS, PhFlu, TMT-B, and WCST)
wereinitiallytransformedintoz-scoresaccordingtoavailable
normative data for age- and gender-matched samples. AD
patients who showed z scores ≤− 1.5 on none or one of the
four executive tasks were classiﬁed into the spared executive
functioning AD group (SEF). On the contrary, AD patients
showing z scores ≤− 1.5 on two or more executive tasks were
grouped into the impaired executive functioning AD group
(IEF).CBIdomainsubscoresweredeterminedforeachofthe
thirteen groups of symptoms as the sum of the individual
frequency scores for each item included in each particular
domain.
Demographic variables, neuropsychological perform-
ance, and behavioral scores were compared between the
groups using Student’s t-test, or Mann Whitney U test
when equal variances could not be assumed. For categorical
variables (e.g., gender), a χ2 test was applied. Correlations
between variables were analyzed through Spearman’s coeﬃ-
cients.
3. Results
Following the patient grouping criteria detailed in the
Methods section, 19 AD patients were classiﬁed into the SEF
group and 11 AD patients into the IEF group. As shown
in Table 1, no signiﬁcant diﬀerences were found between
the groups on age (t28 =− 2.06, P = .47), gender (χ2
1 =
.003, P = .96), dementia severity as measured by the CDR
transformed score (CDR-TS, t28 =− .81, P = .76) and the
CDR sum of boxes (CDR-SOB, t28 =− .73, P = .81), or
the severity of mood symptoms (t28 =− .51, P = .82). A
signiﬁcant diﬀerence was found between the groups on the
total score of the ACE-R (t28 = 4.55, P<. 001), most likely
associated with the poorer executive performance observed
in the neuropsychological tests.
As shown in Figure 1, a comparison of domain subtotal
scores between SEF and IEF revealed no signiﬁcant diﬀer-
ences on the frequency of memory (U = 73.0, P = .19), ori-
entation and attention (U = 89.0, P = .53), everyday skills
(U = 93.5, P = .64), self-care (U = 88.0, P = .50), mood
(U = 75.0, P = .22), beliefs (U = 87.0, P = .47), chal-
lenging behavior (U = 100.0, P = .87), disinhibition (U =
78.0, P = .27), eating habits (U = 88.5, P = .50), sleep
(U = 80.0, P = .31), motivation (U = 140.0, P = .98), and
insight/awareness (U = 72.5, P = .1 7 ) .H o w e v e r ,as i g -
niﬁcant diﬀerence was found between the groups on theCurrent Gerontology and Geriatrics Research 3
Table 1: Comparison of demographic variables and neuropsycho-
logical performance for SEF and IEF patients.
SEF (n = 19) IEF (n = 11)
Age 76.4 (6.4) 78.2 (4.3)
Gender (M:F) 9:10 5:6
Age at onset 74.1 (8.4) 76.1 (2.6)
CDR-TS .66 (.29) .86 (.43)
CDR-SOB 6.2 (1.3) 7.8 (1.5)
BDI-II 5.9 (2.3) 6.4 (2.4)
ACE-R total score 74.8 (9.0) 58.0 (10.3)
Phonological ﬂuency
(no. of words/min)
11.8 (3.2) 8.82 (3.3)
Backward digit span
(no. of digits repeated)
3.59 (1.2) 2.5 (1.0)
Trail Making Test Part B
(seconds to complete)
182 (97) 343 (55)
Wisconsin Card Sorting Test
(no. of correct categories)
3.00 (1.8) 2.33 (2.0)
CDR: clinical dementia rating scale, CDR-TS: CDR transformed score,
CDR-SOB: CDR sum of boxes, BDI-II: Beck depression inventory II, ACE-
R: Addenbrooke’s cognitive examination—revised.
stereotypic and motor behavior frequency of symptoms
(U = 60.5, P = .024).
When patients were considered altogether, no signiﬁ-
cant correlations were found between scores on the CBI
subdomains and neuropsychological performance on either
the ACE-R or any of the four executive tasks, except for a
signiﬁcant positive association between the CBI’s motivation
domain and performance on the WCST (r = .42, P = .02).
Within the SEF group alone, the total ACE-R score was
signiﬁcantly and negatively correlated with the Memory
(r =− .42, P = .05) and the Orientation/Attention domains
of the CBI (r =− .46, P = .04). Within IEF patients,
performance on the WCST (r =− .56, P<. 01) and the
TMT-B (r =− .43, P = .03) correlated signiﬁcantly with the
StereotypiesdomainofCBI.Noothersigniﬁcantcorrelations
were found.
4. Discussion
Our results revealed that AD patients who presented im-
paired executive functioning exhibit signiﬁcantly more ster-
eotypies and repetitive motor behaviors than patients with
AD who show spared performance on this domain. No other
signiﬁcant diﬀerences were found on any of the other neuro-
psychiatric/behavioral domains assessed by the CBI.
Bozeat et al. [14] had demonstrated that of all domains
in the CBI, stereotypic behavior was one of the few that
reliably diﬀerentiated patients with AD from behavioral
variant frontotemporal dementia. Taking into account the
selective involvement of the ventromedial prefrontal cortex
in the latter condition during the earlier stages of the disease
and considering the marked neuropathological changes that
have been described within the frontal cortex of “frontal”
AD patients [5], it comes as no surprise that stereotypic and
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Figure 1: Mean (SD) frequency subtotal for the thirteen domains
assessed by the Cambridge Behavioral Inventory. A signiﬁcant
diﬀerence was observed only for stereotypic and motor behavior
(
∗P <. 05).
aberrant motor behavior—which strongly depend on frontal
cortex activity—were more prominent in dysexecutive AD
patients than in those who show spared executive functions.
In this sense, the results of this preliminary study support the
ideaofafrontalsubgroupofADpatientswhomayhavemore
involvement of the frontal lobes [5, 6] and hence exhibit
more marked neuropsychiatric and behavioral disturbances
[2, 9, 11, 23] associated with the circuitry within the anterior
regions of the brain.
Other behavioral domains assessed by the CBI, however,
have also been strongly associated with the frontal cortex.
For example, studies employing voxel-based morphometry
have related apathy, abnormal eating, and disinhibition with
ventromedial frontal cortices [24, 25]. The question then
remains: why was a signiﬁcant diﬀerence found particularly
for the domain of stereotypic behaviors? Although not
without controversy, one could argue that—even if behavior
obviously results from integrated networks—stereotypic
behavior depends more strongly on frontal striatal compo-
nents [26] while apathy and disinhibition rely more strongly
on frontal cortical regions [27]. One possibility that must
be studied in similar studies using larger samples is that
the underlying pathological changes within “frontal” AD
patients could aﬀect striatal—rather than cortical—aspects
of the frontal circuitry more prominently, or else, earlier in
time. The description of frontal neuropathological patterns
within this subgroup of AD patients is relatively new and
has been done at the level of big brain regions (e.g.,
“frontal cortex”) [5, 6], but studies looking at structural
and biochemical changes of diﬀerent subnetworks within a
brain area may shed light on the heterogeneous nature of
Alzheimer disease. As other authors have recently pointed
out, the diﬀerentiation of a frontal variant of AD is clinically
possible but it still requires pathological veriﬁcation [28].
Ideally, thus, future studies should document neuropatho-
logical changes separately for diﬀerent components of the
frontal corticosubcortical loops (e.g., cortical versus striatal
changes). Speciﬁcally, if cortical (versus subcortical) regions
of the frontal lobes are spared until later in the progression
of “frontal” AD patients, stereotypic behavior may be the4 Current Gerontology and Geriatrics Research
result of early frontal striatal involvement. It must be noted
that all AD patients in the present study were in the mild
stages of the disease. A crucial issue for future studies will be
also to compare “frontal” AD patients in the mild, moderate,
and advanced stages of the disease to determine whether
diﬀerent neuropsychiatric proﬁles emerge at diﬀerent stages
of the disease. Remarkably, general cognitive status, as
measured by the ACE-R, was associated with memory and
attention/orientation scores on the CBI within the group of
AD patients with spared executive functioning. Among those
who had impairments in this domain, however, a negative
association was found between executive functioning (TMT-
B and WCST) and the frequency and severity of stereotypies.
This could also suggest that, at least within “frontal” AD
patients, executive functioning—which depends strongly
on the prefrontal cortex and its striatal connections—may
be related with behavioral disturbances associated with
this brain region. If this is indeed the case, rehabilitation
programs focused on executive functioning could also result
in enhanced behavior.
Byincorporatingastereotypies-speciﬁcaddendumtothe
NPI, Nyatsanza et al. [29] had already shown that, while
complex ritualized behaviors were more frequent in patients
with frontal variant frontotemporal dementia and semantic
dementia, simpler stereotypies were equally common in the
ADpopulation.Forthisreason,futurestudiesshouldalsotry
to determine whether the nature of increased stereotypies in
“frontal” AD patients features more complex behaviors than
those exhibited by the “typical” AD group, as the former
would then mimic more closely those behaviors found in
“frontal” conditions. Evidence derived from studies of this
nature will contribute to the development of more eﬃcient
diﬀerential diagnostic strategies both for AD and for FTD.
Patients with AD who exhibit atypical frontal involvement
could be potentially misdiagnosed as FTD, thus delaying
early pharmacological and nonpharmacological interven-
tions that may be useful for AD but not for FTD. By the same
token, FTD patients presenting with severe amnesia could
be as well misdiagnosed with AD [30]. In this sense, while
the NPI has been used to assess patients with FTD [31, 32]
and the CBI to assess patients with AD [33], combining
the two tools may be helpful for cases of patients whose
behavioralandcognitivedisturbancesmakediﬀerentialdiag-
nosis especially challenging. With recent studies supporting
the idea that the frontal subgroup of AD patients may be
indeed clinically distinguished from other AD patients [28],
future studies on this issue must also compare stereotypies
and motor symptoms with those exhibited by FTD patients
to help develop strategies to distinguish frontal AD patients
from FTD, and amnesic FTD from AD.
The present study has two obvious limitations. On the
one hand, the relatively small sample size of this study de-
mands that the ﬁndings hereby presented be replicated in
larger populations, and as stated above, in diﬀerent stages
of the disease. By doing so and by correcting for multiple
comparisons, we will be able to draw stronger inferences
about the relatively selective deﬁcit in stereotypic behaviors
among “frontal” AD patients. On the other hand, no patho-
logical conﬁrmation of AD diagnosis is available for patients
included in this study. In this respect, it must be noted
that patients were longitudinally followed (between 3 and 6
years), and they all went on to exhibit typical symptoms and
progression of AD. As well, to date, there are unfortunately
nouniversallyacceptedcriteriatodeterminewhatconstitutes
“executive dysfunction”. Our cutoﬀ of more than one execu-
tive task with performance z score < −1.5 SD was based on
previously published procedures [8].
Besides these caveats, the present results have important
clinical implications that derive from the issues mentioned
above. First, they reveal the need to assess neuropsychiatric
and behavioral changes in patients with dementia, as they
have the potential to provide important information about
the challenges faced by patients and their relatives on an
everyday basis. Second, it prompts for the development of
histopathological techniques that will allow for the char-
acterization of structural and biochemical changes within
subcircuits of diﬀerent brain areas, therefore providing
more detailed accounts of pathological changes in diﬀerent
components of complex brain circuits. Third, our ﬁndings
highlight the importance of assessing domains known to rely
on frontal circuitry, such as stereotypic behaviors for various
reasons. On the one hand, because marked behavioral
disturbances that are perceived by others as odd can be
extremely burdensome for relatives of patients with demen-
tia,understandingtheintricatedetailsofabnormalbehaviors
can also help in educating relatives and caregivers about how
to cope with such symptoms. On the other, it can contribute
to the diﬀerential diagnosis of potential AD subtypes and,
furthermore, between diﬀerent types of dementia, such
as FTD. In doing so, the ﬁeld will move towards more
personalized treatment plans by employing relevant and ad
hoc pharmacological and nonpharmacological strategies to
each subpopulation within heterogeneous patient groups.
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